Bayer: Multiple Sclerosis, Relapsing-Remitting trials
The registry lists 17 Multiple Sclerosis, Relapsing-Remitting studies with Bayer as lead sponsor. 0 are open to participants now and 4 have results posted.
Phase 2 1Phase 3 2Phase 4 3No phase 11(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Rehabilitation Study in MS PatientsTerminatedNCT00780455Phase 4Results posted
- BEYOND Follow-up: Betaferon®/Betaseron® Efficacy Yielding Outcomes of a New DoseCompletedNCT00459667Phase 3Results posted
- Safety Study in Relapsing-remitting Multiple Sclerosis (RRMS) Patients Receiving Betaferon or RebifCompletedNCT00317941Phase 4Results posted
- Extension of Prior Study Evaluating Safety and Tolerability of Two Doses of Betaseron® to Treat Relapsing-remitting Multiple SclerosisCompletedNCT00235989Phase 2Results posted
- Medication Usage and Patient Reported Outcomes Evaluation Via myBETAapp in Patients With Multiple Sclerosis Treated With Betaferon: a Pilot StudyCompletedNCT03134573
- Impact of the BETACONNECT Auto-injector on BETASERON Therapy Adherence and Patient SatisfactionCompletedNCT02652091
- BETAEVAL Global - The New BETACONNECT Auto-injector : Adherence and EVALuation of Multiple Sclerosis Patients Treated With BetaferonCompletedNCT02247310
- Noninterventional Study Assessing Cognitive Function and Physical Activity in People With Multiple SclerosisCompletedNCT01491100
- China Betaferon Adherence, Coping and Nurse Support StudyCompletedNCT01436838
- Portuguese Observational Survey to Assess Drug Adherence in Patients With Multiple Sclerosis After Conversion to Betaferon by Using Elements of the BetaPlus Program - Nurse Support, Auto-injectorsCompletedNCT01235455
- Real-World Betaseron Health Economic Outcomes Study for Relapsing Forms of Multiple SclerosisCompletedNCT01158183
- QOLBET Quality Of Life in Patients With Early Relapsing-remitting Multiple Sclerosis Treated With BETaferon® in KoreaWithdrawnNCT01071694
- Injection Management With Betaferon: Influence on Adherence, Patients Satisfaction and Health Related Outcomes (BETAPATH)CompletedNCT00902135
- Observational Study to Analyse the Impact of Nurse Support and Disease Related Factors on Long- Term Adherence to Betaferon TreatmentCompletedNCT00787657
- Success of Titration, Analgesics, and B.E.T.A Nurse Support on Acceptance Rates in Early Multiple Sclerosis (MS) Treatment With BetaseronCompletedNCT00461396
- An Efficacy and Safety Comparison Study of Two Marketed Drugs in Patients With Relapsing-remitting MSCompletedNCT00206648Phase 4
- BEYOND: Betaferon/Betaseron Efficacy Yielding Outcomes of a New Dose in Multiple Sclerosis (MS) PatientsCompletedNCT00099502Phase 3